WAMU 88.5 : News

Filed Under:

Virginia Researchers Make Inroads On Autism Treatment

Play associated audio
Experiments with lab mice have shown some success treating a severe form of autism with bone marrow transplants.
Maria Akhmerova: http://www.flickr.com/photos/12004898@N06/4642070007/
Experiments with lab mice have shown some success treating a severe form of autism with bone marrow transplants.

Virginia scientists are reporting a surprising discovery about autism. Researchers treated mice with an extreme form of the disease and were able to restore normal function and extend their lives.

Rett Syndrome is a rare and extreme form of autism in which boys die before or shortly after birth, and girls suffer serious disability.

"Interestingly, the girls are born normal, and the disease starts to appear around 6-18 months of age. So basically you have a normal girl, and suddenly you see reversal in her development," says Jonathan Kipnis, an associate professor of neuroscience at the University of Virginia, who led an intriguing study on mice.

If scientists make a genetic alteration, Kipnis says, they can produce rodents who have a disease very much like Rett: "Male mice are born, and they die about 8 weeks of age, and the female mice live almost normal lifespan, but they develop disease around 4 months of age. By a year it's a very, very severe disease."

Kipnis and his colleagues knew that the immune system could be a factor in brain function.

"For example, if we take T-lymphocytes from normal mice, we can make them stupid, or if we take stupid mice, inject them with some types of immune cells and make them smart," says Kipnis.

And a previous study had shed light on the brains of mice with this extreme form of autism. They knew that the same protein which is mutated in Rett Syndrome is needed for the growth of some types of immune cells. The immune system is easy to fix in mice, as it is also in human patients, by bone marrow transplantation. So they were able to restore normal function and extend the animals lives by performing bone marrow transplants.

"Male mice are dying around 6-10 weeks of age, and our oldest male mouse celebrated his first birthday very recently, so the results are really amazing," says Kipnis. "We never expected to get anything like that, but then when the mice were 10 weeks and they looked normal, we said 'Let's wait, 12 weeks, 14 weeks, 16 weeks, 20 weeks.' And then we realized we had something really, really serious on our hands."

Kipnis says this work raises many more questions which will have to be answered before bone marrow transplant could be tried in humans with autism, but he says this novel approach to treatment does offer reasons for hope.

His team's findings are published in the Journal Nature.

WAMU 88.5

Art Beat With Lauren Landau, Aug. 28, 2015

This weekend you can pay tribute to the late King of Pop or attend the last Jazz in the Garden performance of the summer.
NPR

How Brewers Are Churning Out Tangy Sours Without The Hefty Price Tag

Sour beers are made by deliberately adding microbes to create complex brews with a crisp, acidic taste. But that process takes lots of time and money, resulting in a pricey final product. Until now.
NPR

Is Donald Trump Nice Enough?

The GOP frontrunner is happy to pile on criticisms and jabs at his fellow rivals, but he gets testy if you criticize him.
NPR

CEO Of Cheating Website Ashley Madison, Noel Biderman, Has Stepped Down

The parent company, Avid Life Media, has been reeling since hackers released information on 33 million of its customers. The company did not immediately appoint a new CEO.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.